Investing.com - Abbott Labs reported on Wednesday fourth quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $0.95 on revenue of $8.31B. Analysts polled by Investing.com anticipated EPS of $0.95 on revenue of $8.26B. That was in comparison with EPS of $0.81 on revenue of $7.77B in the same quarter a year before.Abbott Labs had reported EPS of $0.84 on revenue of $8.08B in the previous quarter.Analysts are forecasting EPS of $0.73 and revenue of $8B in the next quarter.
Abbott Labs stock's are up 3.3% since the start of the year and is trading at $90.26 , still down 0.34% from its 52 week high of $90.04 set on January 21.
Abbott Labs shares gained 0.59% to trade at $90.26 in pre-market trade after the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs's report follows an earnings beat by J&J on Wednesday, who reported EPS of $1.88 on revenue of $20.75B, compared to expected EPS of $1.87 on revenue of $20.78B.
Novocure Ltd had beat expectations on October 31, 2019 with third quarter EPS of $0.02 on revenue of $92.06M, was in comparison with anticipated for EPS of $-0.04 on revenue of $86.94M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar